impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Full Papers

 

Fitbit as an activity monitor in idiopathic inflammatory myopathy: results from a real-world cohort

1, 2, 3, 4, 5, 6, 7, 8

 

  1. Internal medicine, University of Pittsburgh Medical Center Mercy, Pittsburgh, PA, USA.
  2. Rheumatology, Bnai-Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel.
  3. Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA.
  4. Division of Rheumatology and Clinical Immunology, Massachusetts General Hospital, Boston, Massachusetts, MA, USA.
  5. Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  6. Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  7. Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  8. Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. aggarwalr@upmc.edu

CER19099
2026 Vol.44, N°2
PI 0345, PF 0352
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 41738257 [PubMed]

Received: 14/07/2025
Accepted : 13/02/2026
In Press: 24/02/2026
Published: 24/02/2026

Abstract

OBJECTIVES:
Idiopathic inflammatory myopathies are systemic autoimmune diseases that can be associated with debilitating muscle weakness and significant limitations in daily activities. Physical activity monitors (PAM) are recognised measures of the frequency and intensity of physical activities. The aim of this study is to investigate the psychometric properties and performance of Fitbit® as a wearable activity tracker in IIM. METHODDS: Myositis Patient Centred Tele-Research (MyPACER) is a multi-centre observational prospective study conducted over 6 months recruiting patients with dermatomyositis (DM), necrotising myopathy (NM) and polymyositis (PM). The study had two cohorts, a Tele-Research Cohort (TRC, remote enrolment) and a Centre-Based Cohort (CBC, in person enrolment). Functional and patient-reported outcome measures were completed monthly. Participants were asked to use their wrist-worn Fitbit® for 7 consecutive days per month. Average daily steps per minute and average peak 1-minute cadence were evaluated as PAM measures.
RESULTS:
A total of 120 IIM patients (mean age 55.5±13.43; 75% females; 81% White) were enrolled; 82 in the TRC group and 38 in the CBC group. There were 51% DM, 39% PM, and 9% NM. The TRC and CBC cohorts were similar in demographics and disease subtypes. Gender, race/ethnicity, or disease subtypes were not associated with PAM measures. Compliance with Fitbit® wear protocol was very high, with similar results for remote or local recruitment. Average steps/min and average peak 1-minute cadence showed strong test-retest reliability [r=0.89 (p<0.0001 and r=0.86 (p= 0.0001)]. A longitudinal significant positive correlation was found between physical activity metrics and patient-reported and functional measures.
CONCLUSIONS:
In a large IIM cohort, Fitbit® PAM variables demonstrate favourable compliance and psychometric properties with strong test-retest reliability and validity. PAMs can complement current measurements to remotely track patient performance, quality of life, and disease activity.

DOI: https://doi.org/10.55563/clinexprheumatol/rihi7r

Rheumatology Article

Rheumatology Addendum